Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125345-24-000148
Filing Date
2024-08-06
Accepted
2024-08-06 16:01:20
Documents
55
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgnx-20240630.htm   iXBRL 10-Q 807086
2 EX-31.1 exhibit31-1q22024.htm EX-31.1 9065
3 EX-31.2 exhibit31-2q22024.htm EX-31.2 9067
4 EX-32.1 exhibit32-1q22024.htm EX-32.1 3995
5 EX-32.2 exhibit32-2q22024.htm EX-32.2 3830
  Complete submission text file 0001125345-24-000148.txt   4640772

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20240630.xsd EX-101.SCH 30922
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20240630_cal.xml EX-101.CAL 45841
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20240630_def.xml EX-101.DEF 187651
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20240630_lab.xml EX-101.LAB 479556
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20240630_pre.xml EX-101.PRE 332783
57 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20240630_htm.xml XML 523379
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 241178966
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)